Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-08-24
2008-08-12
Weber, Jon P (Department: 1654)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S402000, C530S412000, C530S414000, C530S418000, C530S427000, C530S829000, C424S529000, C424S533000, C514S006900, C514S832000
Reexamination Certificate
active
07411044
ABSTRACT:
A substantially tetramer free hemoglobin solution and a method for producing a substantially tetramer free hemoglobin solution. The method includes polymerizing a solution of hemoglobin, treating the polymerized hemoglobin solution to partially degrade the polymer to tetramer and removing tetramer from the hemoglobin solution.
REFERENCES:
patent: 4001200 (1977-01-01), Bonsen et al.
patent: 4001401 (1977-01-01), Bonsen et al.
patent: 4049673 (1977-09-01), Scheinberg
patent: 4053590 (1977-10-01), Bonsen et al.
patent: 4061736 (1977-12-01), Morris et al.
patent: 4113853 (1978-09-01), Funakoshi et al.
patent: 4136093 (1979-01-01), Bonhard et al.
patent: 4485174 (1984-11-01), Chiang et al.
patent: 4526715 (1985-07-01), Kothe et al.
patent: 4529719 (1985-07-01), Tye
patent: 4650786 (1987-03-01), Wong
patent: 4711852 (1987-12-01), Jacobson et al.
patent: 4761209 (1988-08-01), Bonaventure et al.
patent: 4826811 (1989-05-01), Sehgal et al.
patent: 4835097 (1989-05-01), Saunders
patent: 4857636 (1989-08-01), Hsia
patent: 4861867 (1989-08-01), Estep
patent: 5028588 (1991-07-01), Hoffman et al.
patent: 5061688 (1991-10-01), Beissinger et al.
patent: 5084558 (1992-01-01), Rausch et al.
patent: 5194590 (1993-03-01), Sehgal et al.
patent: 5206075 (1993-04-01), Hodgson, Jr.
patent: 5217648 (1993-06-01), Beissinger et al.
patent: 5241031 (1993-08-01), Mehta
patent: 5272236 (1993-12-01), Lai et al.
patent: 5278272 (1994-01-01), Lai et al.
patent: 5296465 (1994-03-01), Rausch et al.
patent: 5380824 (1995-01-01), Marschall et al.
patent: 5438041 (1995-08-01), Zheng et al.
patent: 5464814 (1995-11-01), Sehgal et al.
patent: 5691452 (1997-11-01), Gawryl et al.
patent: 5691453 (1997-11-01), Wirtz et al.
patent: 5695840 (1997-12-01), Mueller
patent: 5747649 (1998-05-01), Sehgal et al.
patent: 5789376 (1998-08-01), Hsia
patent: 5840852 (1998-11-01), Rausch et al.
patent: 5895810 (1999-04-01), Light et al.
patent: 5929031 (1999-07-01), Kerwin et al.
patent: 5955581 (1999-09-01), Rausch et al.
patent: 5988422 (1999-11-01), Vallot
patent: 5998361 (1999-12-01), Bucci et al.
patent: 6027776 (2000-02-01), Mueller
patent: 6076457 (2000-06-01), Vallot
patent: 6133425 (2000-10-01), Sehgal et al.
patent: 6150507 (2000-11-01), Houtchens et al.
patent: 6271351 (2001-08-01), Gawryl et al.
patent: 6288027 (2001-09-01), Gawryl et al.
patent: 6323320 (2001-11-01), Sehgal et al.
patent: 6498141 (2002-12-01), DeWoskin et al.
patent: 6552173 (2003-04-01), Sehgal et al.
patent: 7135553 (2006-11-01), Avella et al.
patent: 2002/0065211 (2002-05-01), Jacobs, Jr. et al.
patent: 0 361 720 (1990-04-01), None
patent: WO 97/35883 (1997-10-01), None
patent: WO 00/21366 (2000-04-01), None
Gould, S.A., et al.,The Life-Sustaining Capacity of Human Polymerized Hemoglobin when Red Cells Might Be Unavaiable, Journal of the American College of Surgeons, 195 (4):445-455 (Oct. 2002).
Carson, J.L., et al.,Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion, Transfusion, 42: 812-818 (Jul. 2002).
Moore, F.A., et al.,Trauma Resuscitation, ACS Surgery-Principles & Practice, 31-61 (2002).
American College of Surgeons Committee on Trauma. Advanced Trauma Life Support Program for Physicians 1997 Instructional Manual, 6th, ed. Chicago: American College of Surgeons; 98-117 (1997).
Farion, K.J., et al.,Changes in Red Cell Transfusion Practice among Adult Trauma Victims, J. Trauma, 44(4):583-587 (1998).
Baker, J.B., et al.,Type and Crossmatch of the Trauma Patient, J. Trauma, 50(5):878-881 (May, 2001).
DeFoe, G.R., et al.,Lowest Hematocrit on Bypass and Adverse Outcomes Associated with Coronary Artery Bypass Grafting, Ann Thorac Surg., 71:769-776 (2001).
Wu, W.C., et al.,Blood Transfusion in Elderly Patients with Acute Miyocardial Infarction, New England Journal of Medicine, 345(17):1230-1236 (Oct. 2001).
Practice Guidelines for Blood Component Therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy, Anesthesiology 84(3):732-747 (Mar. 1996).
Consensus Conference. Perioperative Red Blood Cell Transfusion, JAMA 260(18): 2700-2703 (Nov. 1988).
Gould, S.A., et al.,Fluosol DA-20 As A Red Cell Substitute in Acute Anemia, New England Journal of Medicine, 314(26):1653-1656 (Jun. 1986).
Spence, R.K., et al.,Fluosol DA-20 in the treatment of severe anemia: Randomized, controlled study of 46 patients, Critical Care Medicine, 18(11):1227-1230 (Nov. 1990).
Spence, R.K., et al.,Is Hemoglobin Level Alone a Reliable Predictor of Outcome in the Severely Anemic Patient?The American Surgeon, 58(2):92-95 (1992).
Carson, J.L., et al.,Severity of Anaemia and Operative Mortality and Morbidity, Lancet 1(8588):727-729 (Apr. 1988).
Carson, J.L., et al.,Effect of anaemia and cardiovascular disease on surgical mortality and morbidty, Lancet, 348(9034):1055-1060 (Oct. 1996).
Viele, M.K., et al.,What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witnesses, Transfusion 34(5):396-401 (1994).
Sehgal L.R., et al.,Polymerized pyridoxylated hemoglobin: A red cell substitute with normal oxygen capacity, Surgery 95:433-438 (1984).
Amberson, W.R., et al.,Clinical Experience with Hemoglobin-Saline Solutions, J. Applied Physiology, 1(7):469-489 (Jan. 1949).
Brandt, J.L., et al.,The Effects of Hemoglobin Solutions on Renal Functions in Man, Blood, 6:1152-1158 (1951).
Miller, J.H., et al.,The Effect of Hemoglobin on Renal Function in The Human, Journal of Clinical Investigation, 30:1033-1040 (Jul. 1951).
Savitsky, J.P., et al.,A clinical trial of stroma-free hemoglobin, Clinical Phamacology Journal, 23(1):73-80 (Jan. 1978).
Carmichael, F.J., et al.,A phase I study of oxidized raffinose cross-linked human hemoglobin, Crit Care Med., 28(7):2283-2292 (2000).
Kasper, S.M., et al.,Effects of a Hemoglobin-Based Oxygen Carrier(HBOC-201)on Hemodynamics and Oxygen Transport in Patients Undergoing Preoperative Hemodiulution for Elective Abdominal Aortic Surgery, Anesth Analg, 83:921-927 (1996).
LaMuraglia, G.M., et al.,The reduction of the allogenic transfusion requirement in aortic surgery with a hemoglobin-based solution, J. Vascular Surgery, 31(2):299-308 (Feb. 2000).
Sloan, E.P., et al.,Diaspirin Cross-Linked Hemoglobin(DCLHb)in the Treatment of Severe Traumatic Hemorrhagic Shock, JAMA 282:1857-1864 (Nov. 1999).
Gould, S.A., et al.,Clinical Utility of Human Polymerized Hemoglobin as a Blood Substitute AfterAcute Ttrauma and Urgent Surgery, J. Trauma 43(2):325-332 (Aug. 1997).
Gould, S.A., et al.,The First Randomized Trial of Human Polymerized Hemoglobin as a Blood Substitute in Acute Trauma and Emergent Surgery, J Am Coll Surg 187(2):113-122 (Aug. 1998).
Vengelen-Tyler, V., American Association of Blood Banks Technical Manual. 13thed., Bethesda (MD): American Association of Blood Banks, p. 389-396 (1999).
Huston, P., et al.,Withholding Proven Treatment in Clinical Research, New England Journal of Medicine 345(12):912-914 (Sep. 2001).
Emanuel, E.J., et al.,The Ethics of Placebo-Controlled Trials- A Middle Ground, New England Journal of Medicine, 345(12):915-914 (Sep. 2001).
Carson, J.L, et al.,Mortality and morbidity in patients with very low blood counts who decline blood transfusion, Transfusion, 42:812-818 (Jul. 2002).
Reiner, A.P.,Massive Transfusion, Perioperative Transfusion Medicine, p. 351-364 (1998).
Weiskopf, R.B., et al.,Human Cardiovascular and Metabolic Response to Acute, Severe Isovolemic anemia, JAMA 279(3): 217-221 (Jan. 1998).
Wilkerson, D.K., et al.,Limits of cardiac compensation in anemic baboons, Surgery, 103(6):665-670 (1988).
Levy, P.S., et al.,Oxygen Extraction Ratio: A Valid Indicator of Transfusion Need in a Limited Coronary Vascular Reserve?J. Trauma 32(6):769-774 (Jun. 1992).
Schwartz, J.P., et al.,The Influence of Coronary Stenosis On Transfusion Need., Cardiothoracic Surgery, Surgical Forum XLIV:226-228 (1993).
Moss, G.S., et al.,Transport of Oxygen and Carbon Dioxide by Hemoglobin-Saline Solution in the Red Cell-Free Primate, Surg. Gynecol Obstet, 142:357-362 (Mar. 1976).
Frantantoni, J.C.,Points to consider o
Avella Anthony
DeWoskin Richard
Doubleday Marc
McDonnell Boehnen & Hulbert & Berghoff LLP
Mohamed Abdel A
Northfield Laboratories, Inc.
Weber Jon P
LandOfFree
Polymerized hemoglobin solutions having reduced amounts of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymerized hemoglobin solutions having reduced amounts of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymerized hemoglobin solutions having reduced amounts of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4004612